Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-6160117th Congress
Access to Rare Indications Act of 2021
Sponsored By: Representative Matsui, Doris O. [D-CA-7]
Unknown
Summary
Access to Rare Indications Act of 2021 This bill provides for coverage under the Medicare prescription drug benefit, Medicaid, and private health insurance of certain drugs that are used to treat rare diseases or conditions (i.e., diseases or conditions that affect 200,000 or fewer individuals). Such drugs must be supported by peer-reviewed research or medical experts and must not have been reviewed unfavorably in specified compendia or used in a way that conflicts with approved labels.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Matsui, Doris O. [D-CA-7]
CA • D
Cosponsors
Rep. Thompson, Mike [D-CA-4]
CA • D
Sponsored 12/7/2021
Rep. Mullin, Markwayne [R-OK-2]
OK • R
Sponsored 12/7/2021
Rep. Kelly, Mike [R-PA-16]
PA • R
Sponsored 12/7/2021
Rep. Fitzpatrick, Brian K. [R-PA-1]
PA • R
Sponsored 2/18/2022
Rep. Stansbury, Melanie A. [D-NM-1]
NM • D
Sponsored 7/7/2022
Rep. Evans, Dwight [D-PA-3]
PA • D
Sponsored 10/7/2022
Rep. Sherrill, Mikie [D-NJ-11]
NJ • D
Sponsored 11/29/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov